Fatty acid biosynthesis is a vital facet of bacterial physiology that is carried out by a set of discrete enzymes collectively known as the as the type II fatty acid synthase system (FAS-II 3 ) (for reviews, see (1,2)).
The abbreviations used are: ACP, acyl carrier protein; FabT, fatty acid biosynthesis repressor of S. pneumoniae; FAS-II, dissociated type II fatty acid synthase; 18:1'11, cis-vaccenic acid; 18:1'9, oleic acid; 16:0, palmitic acid; fab genes, general term referring to all the genes encoding the enzymes of FAS-II; LP, a 279 bp DNA sequence containing the FabT palindrome.
Fatty acid biosynthesis is a vital facet of bacterial physiology that is carried out by a set of discrete enzymes collectively known as the as the type II fatty acid synthase system (FAS-II 3 ) (for reviews, see (1, 2) ).
Fatty acid synthesis is an energy intensive process, and the rate of fatty acid production is tightly regulated to ensure the supply of membrane phospholipid exactly matches the demand (1, 2) . The intermediates in FAS-II are carried on ACP, a 9 kDa, 4-helix protein that carries the fatty acid as a thioester attached to its 4c-phosphopantetheine prosthetic group (3). ACP is one of the most interactive proteins in biology binding to a large number of intracellular proteins in a variety of biochemical pathways (4) . The long-chain acyl-ACP end products of FAS-II (primarily 16 and 18 carbon fatty acids) are established biochemical regulators of the rate of FAS-II in Escherichia coli. These acylACPs inhibit the initiation of FAS-II though their feedback regulation of FabH (5), and limit the rate of FAS-II through their inhibition of acetylCoA carboxylase (6) . The genetic regulation of FAS-II in E. coli is focused on two genes, fabA and fabB. Transcription of the fabA and fabB genes is governed by two transcriptional regulators: FadR, the activator; and FabR, the repressor (for reviews, see (2, 7, 8) ). FadR was discovered as a repressor of the E-oxidation regulon (9, 10) , and subsequently discovered to also be an activator of fabA and fabB transcription (11) (12) (13) . The ligands that control FadR DNA binding are acyl-CoAs that are t12 carbons long (14) (15) (16) (17) (18) (19) (20) . FabR was identified as a protein that bound to a palindrome located in the fabB and fabA promoters (21) where it functions as a transcriptional repressor based on the increase in fabA and fabB mRNA in a fabR deletion mutant (22 (24, 25) . In contrast, the human pathogen, S. pneumoniae, has a distinctive clustering of the fab genes within the genome coupled with an atypical mechanism for unsaturated fatty acid biosynthesis (26) and enoyl-ACP reduction (26, 27) .
The second gene in the fab cluster, fabT (Fatty Acid Biosynthesis Transcriptional regulator), encodes a helix-turn-helix DNA binding protein belonging to the MarR superfamily of transcriptional regulators that binds to a sequence-specific DNA palindrome located within the two promoters that control fab gene expression (28) . A knockout of the fabT gene leads to an increase in the expression of all FAS-II genes with the exception of fabM (28) .
Although the role of FabT as a repressor of fatty acid biosynthesis gene expression is clear from the gene knockout experiments, the increased expression of FabT does not decrease the expression of the FAS-II genes (28) suggesting the presence of a limiting intracellular regulatory ligand that positively controls FabT association with its DNA binding elements. This study identifies this activating ligand as long-chain acyl-ACP, which increases the affinity of FabT for its sequence-specific DNA binding sites. Thus, the acyl-ACP endproducts of fatty acid synthesis act as a feedback regulators of FAS-II gene expression.
EXPERIMENTAL PROCEDURES
Materialsʊ6RXUFHV RI supplies were: Avanti Polar Lipids Inc., oleoyl-lysophosphatidic acid, palmitoyl-lysophosphatidic acid, oleoylCoA, palmitoyl-CoA; TriLink BioTechnologies, guanosine-3c,5c-bisdiphosphate (ppGpp); Fluka, 4-hydroxy-6-methyl-2-pyrone; Sigma, sodium salicylate, and malonyl-CoA; Invitrogen, Novex ® 6% DNA Retardation Gel, Novex (31) were prepared following literature procedures. Expression and purification of the aminoterminal His-tagged FabT was performed as described (28) . The removal of the His-tag did not alter FabT DNA binding properties, so for most of the experiments, the His-tagged version of FabT was used.
TTTGACTGTCAAATT) in the center and was extended on both sides to obtain a long probe containing 279 base-pairs (LP). The use of this probe, rather than a shorter oligonucleotide, was required for our experiments to counteract the charge on the highly positive FabT (pI = 9.4) to give rise to a FabTxDNA complex with a net negative charge that would migrate into a Novex ® 6% DNA Retardation Gel (pH 8.3). FabT binding was specific for the palindrome sequence identified previously within LP (28) based on the ability of an unlabelled oligonucleotide probe containing the palindrome sequence to prevent binding of FabT to LP. A scrambled oligonucleotide had no effect. LP was prepared starting with the double-stranded 35 bp fragment from the fabK promoter, 5c-TTAGGTAATAGTTTGACTGTCAAATTATGGT GAAA, containing the underlined palindrome sequence in the middle was generated from two custom synthesized complementary singlestranded oligonucleotides. The resulting bluntend DNA was ligated into pCRII-Blunt TOPO (Invitrogen) to yield plasmid pAJ050, which served as template DNA to amplify LP using PCR primers 5c-CAGGAAACAGCTATGACCATGATTACG and 5c-GTAAAACGACGGCCAGTGAATTG. Following purification, LP was 32 P-labeled using the DNA 5c-End-Labeling Kit (Promega). We also used a DNA probe constructed from the related palindrome that binds FabT located in the fabT-fabH-acpP promoter (GTTTTGATTGTAAAAGT), and in all cases obtained the same results, although FabT bound this palindrome less tightly than the more perfect palindrome located in the fabK promoter.
Electrophoretic Mobility Shift Assayʊ)DE7 DNA-binding was assessed by gel mobility shift assays using Novex ® 6% DNA Retardation Gel (Invitrogen) and 32 P-labeled LP.
In a representative assay, 10 pM 32 P-labeled LP, 60 nM FabT and 0-1500 nM acyl-ACP were mixed in a buffer containing 0.5x Novex ® Hi-Density TBE sample buffer (Invitrogen) and 50 mM NaCl; the mixture was incubated at 25qC for 5 min and then 15 Pl (3000 dpm) was loaded per lane. The gel was exposed to a phosphor screen, and was scanned with a Typhoon 9600 PhosphorImager (GE Healthcare).
Gel Filtration Chromatographyʊ,QWHUDFWLRQ between FabT and acyl-ACP was assessed based on the elution profile of [1- 
AlphaScreen
Binding AssayʊThe AlphaScreen assay is a bead-based technology developed for assessing proteinprotein interactions in a homogeneous microplate format (32, 33) . We developed a binding assay in 384-well microplate format using this technology to monitor interaction between FabT and acyl-ACP, which employed the Nickel Chelate Histidine Detection Kit (PerkinElmer), amino-terminal His-tagged FabT and biotinylated acyl-ACPs. EZ-Link FPLC (GE Healthcare) and eluted in the same buffer collecting 200 Pl fractions in a 96-well microtiter plate. The radioactivity in 100 Pl aliquots from each fraction was determined using liquid scintillation counting.
® Sulfo-NHS-LC-Biotinylation Kit (Pierce) was used to label ACPs. The AlphaScreen assay is a sensitive method to reliably determine relative binding affinities, although the high avidity of the assay leads to an overestimate of the strength of the interaction compared to other techniques (34) . Reagents were diluted with buffer containing 25 mM HEPES at pH 7.4, 400 mM LiCl and 1 mg/ml bovine serum albumin as follows: FabT, to a stock concentration of 200 nM; acyl-ACPs, serial dilution between 104 nM and 1.7 nM; streptavidin-coated donor beads and nickel chelate acceptor beads, to 0.1 mg/ml. In a representative experiment, 7.5 Pl biotinylated acyl-ACP was mixed with 7.5 Pl His-tagged FabT, 5 Pl donor beads and 5 Pl acceptor beads, followed by incubation in the dark at 25qC for one hour and data collection on a Fusion-Alpha plate reader (Packard). Each assay point was determined in triplicate. Background was obtained by eliminating FabT from the well mixture and the resulting signal to background ratio was approximately 600:1. There was no signal generated when Histagged DkgB (35) 
RESULTS

Long-chain Fatty Acyl-ACPs Activate FabT DNA-bindingʊ)DE7
IXQFWLRQV DV a transcriptional repressor based on the upregulation of the 12-gene fab cluster in a S. pneumonia strain lacking FabT (28) . However, increased expression of FabT using a multicopy plasmid did not suppress expression of the fatty acid biosynthetic genes in the wildtype strain (28) , suggesting that FabT repression of the fab genes was positively controlled by an intracellular ligand that regulates FabT's affinity for its DNA binding sites. To test this hypothesis, we developed an electrophoretic mobility shift assay to screen candidate intracellular metabolites related to fatty acid synthesis for their ability to promote the interaction between FabT and it sequencespecific DNA binding site. Although the FabT repressor will bind to its cognate DNA palindrome if enough protein is added to the assay (28), our strategy was to detect interactions that increase the affinity of FabT for DNA, therefore the amount of FabT protein used in the screen was below that required to observe DNA binding in the absence of an effector.
Most of the metabolites tested, including malonyl-CoA, had no effect on FabT DNA binding (Fig. 1A) . However, long-chain acyl-ACP end-products of fatty acid synthesis significantly increased FabT DNA binding (Fig.  1A) . FabT binding to LP in the presence of acyl-ACP was not detected in assays spiked with the oligonucleotide containing the palindrome previously identified to bind to FabT (28) (not shown). 16:0-ACP and 18:1'11-ACP were selected for the screen because 16:0 (22%) and 18:1'11 (43%) are two abundant fatty acid chains found in S. pneumoniae phospholipids (28) . Also, 18:1'9-CoA slightly increased FabT DNA binding (Fig. 1A) . Although the difference in the migration of the DNA shifted with acyl-ACP and acyl-CoA was small, the band shifted with the acyl-CoA consistently ran further into the gel than the band shifted with acyl-ACP (Fig. 1A) . We next tested a series of acyl-ACP chain lengths to determine the acyl-ACP chain length dependence for FabT DNA binding (Fig. 1B) . 18:1'11-ACP was the most potent activator of FabT binding, and the ability of acyl-ACP to promote FabT-DNA interaction fell as the chain length decreased, illustrating that the two endproducts of the pathway were the most potent regulators of FabT.
The observation that 18:1'9-CoA increased FabT binding to DNA was curious because there is no evidence that these fatty acid metabolites exist in S. pneumoniae. There are no predicted acyl-CoA synthetases found in the genome and there are no E-oxidation enzymes present either, a major route for acyl-CoA metabolism in bacteria like E. coli. Furthermore, the PlsY and PlsC acyltransferases of S. pneumoniae do not recognize acyl-CoA thioesters and exclusively utilize acyl-ACP substrates, ruling out a role for acyl-CoA in membrane lipid synthesis in this organism (29) . Therefore, we compared the concentration dependence of acyl-ACP and acyl-CoA to promote FabT DNA binding (Fig.  2) .
18:1'11-ACP was more effective in enhancing FabT DNA binding than 16:0-ACP, although FabT binding was saturable in both cases.
FabT DNA binding promoted by 18:1'9-CoA occurred at a much lower affinity and failed to saturate. 16:0-CoA was even less effective. These data show that 18:1'11-ACP, corresponding to the most abundant fatty acid in S. pneumoniae membranes, was the most effective FabT ligand. We attribute the activity of 16:0-CoA and 18:1'9-CoA to it acting as a weak-binding analog of acyl-ACP. It is widely appreciated that acyl-CoA and N-acetylcystamine thioesters act as ACP analogs that function in FAS-II enzyme systems at much lower affinities than their corresponding acylACPs (36) (37) (38) .
Interaction between Acyl-ACP and FabTʊWe found no evidence for the transfer of the labeled fatty acid to FabT from [ These data suggested the DNA complex observed in the gel retardation assays was a FabTxacyl-ACPxDNA ternary complex. This idea was confirmed using anti-ACP IgG to signal the presence of ACP in the complex revealed by a "supershift" the FabTxacylACPx[ 32 P]DNA complex in the presence of anti-ACP IgG (Fig. 3A) . Next, we determined if the FabTxacyl-ACP complex formed in the absence of DNA. Gel filtration chromatography was used to separate acyl-ACP from FabTxacyl-ACP complexes (Fig. 3B) . FabT alone eluted at 15.8 ml, which was slower than the FabTxacyl-ACP complex eluting at 16.5 ml, but faster than the elution of acyl-ACP at 15.5 ml. These data clearly show the formation of a FabTxacyl-ACP complex in the absence of DNA. A sensitive, direct binding AlphaScreen assay was used to determine the rank order of FabT binding by different acyl-ACP species (Fig. 3C) .
This assay yielded the same apparent dissociation constants for both longand medium-chain ACPs, and higher apparent dissociation constants for malonyl-ACP and ACP. These data show that while the presence of a fatty acid chain on acyl-ACP increases the affinity of FabT for DNA, all acyl-ACP species bind with approximately the same apparent affinity. These data, taken together with the information in Fig. 1B , leads to the conclusion that the interaction between FabT and acyl-ACP is primarily mediated by FabT-ACP protein interactions and that FabT monitors the entire acyl-ACP pool in vivo. However, the length of the fatty acid chain is critical to triggering the conformational change that converts FabT from a low-to a high-affinity DNA binding protein. Thus, FabT functions in much the same way as DesT, a transcription factor from Pseudomonas aeruginosa that binds to all acyl-CoA species equally, but only those with a double bond induce the conformational change necessary for DNA binding (39) .
DISCUSSION
Our discovery reveals an important new level of FAS-II regulation by acyl-ACP (Fig. 4) . Acyl-ACP binds to the FabT repressor and significantly increases its affinity for its binding sites in the two promoters in the fab gene cluster. The potency of acyl-ACP increases with increasing chain-length, and the most effective acyl-ACP, 18:1'11-ACP (Fig. 2) , corresponds to the most abundant fatty acid (48%) found in S. pneumoniae membrane phospholipids (28) . These observations lead to a model where the end-products of FAS-II act as feedback inhibitors of the transcription of the genes encoding the enzymes in the biosynthetic pathway (Fig. 4) . This regulatory circuit coupled with the genetic organization of the FAS-II gene cluster ensures that transcription of the entire fab gene set is coordinately linked to the level of acyl-ACP precursors to membrane phospholipids. This genetic regulatory loop is complemented by the biochemical regulation of FAS-II by acyl-ACPs through their ability to inhibit two key enzymes involved in the initiation and maintenance of the pathway, FabH (5) and acetyl-CoA carboxylase (6) (Fig. 4) . Both of these enzymes are negatively regulated by acyl-ACP with the longer chain lengths being the most potent allosteric effectors. Finally, the regulatory roles for acyl-ACP end-products of FAS-II depicted in Fig. 4 points to coordination of membrane phospholipid synthesis with other macromolecular processes occurring at the acyltransferase step.
The most thoroughly studied FAS-II transcriptional regulator is FapR (23) (24) (25) . This protein acts as a repressor to coordinately control the dispersed genes of FAS-II in B. subtilis. In this case, malonyl-CoA is the ligand that releases FapR from DNA. Thus, the FabT and FapR systems appear quite different. FabT participates in a defined feedback loop (Fig. 4) , whereas FapR operates by a less wellcharacterized feedforward regulatory loop. Acetyl-CoA carboxylase is perhaps a regulatory target for ligands that coordinate membrane biogenesis with cell growth in B. subtilis, but the details of how acetyl-CoA carboxylase is regulated and how a feedforward system could coordinate the rate of FAS-II with the demand for acyl-ACP remains to be defined. Another important transcriptional repressor of the type II system is FabR (22) , but nothing is known about its regulatory ligand. A continued effort to understand these regulatory interactions is warranted due to their importance in maintaining bacterial membrane lipid homeostasis and the potential to exploit these control systems for the development of novel antibacterial therapeutics.
FIGURE LEGENDS
FIGURE 1. Long-chain acyl-ACP induces FabT DNA-binding activity. A, Identification of the specific ligands that promote FabT DNA binding using the gel electrophoretic mobility shift assay described under "Experimental Procedures." Each lane contained 60 nM purified FabT, 1.5 PM of the indicated compounds and 10 pM 32 P-labeled DNA fragment (LP). TAL, 4-hydroxy-6-methyl-2-pyrone. B, Acyl-ACP chain length specificity in the activation of FabT DNA binding determined under the same assay conditions. FIGURE 2. Long-chain acyl-CoA are lower affinity analogs of acyl-ACP. Electrophoretic mobility shift assays were performed using 60 nM purified FabT, 10 pM 32
